Showing results (1361-1370 of 1,388) with videos related to

Sort By:
Pageof 139
Seminars in Arthritis and Rheumatism|December 16, 2011
Registry of the Spanish network for systemic sclerosis: clinical pattern according to cutaneous subsets and immunological statusCarmen Pilar Simeón-Aznar, Vicent Fonollosa-Plá, Carles Tolosa-Vilella, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|January 29, 2025
Contribution of Blood Biomarkers to Multiple Sclerosis DiagnosisManuel Comabella, Agustín Pappolla, Enric Monreal, et al.
Medicine|October 30, 2015
Registry of the Spanish Network for Systemic Sclerosis: Survival, Prognostic Factors, and Causes of DeathC P Simeón-Aznar, V Fonollosa-Plá, Carles Tolosa-Vilella, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|February 23, 2021
Omalizumab outcomes for up to 6 years in pediatric patients with severe persistent allergic asthmaAntonio Nieto García, Teresa Garriga-Baraut, Ana María Plaza Martín, et al.
Brain : a Journal of Neurology|December 21, 2024
De-escalating and discontinuing disease-modifying therapies in multiple sclerosisGéraldine Androdias, Jan D Lünemann, Elisabeth Maillart, et al.
Clinical and Experimental Allergy : Journal of the British Society for Allergy and Clinical Immunology|September 30, 2024
Whole Exome Sequencing Identifies Epithelial and Immune Dysfunction-Related Biomarkers in Food Protein-Induced Enterocolitis SyndromeAlba Camino-Mera, Jacobo Pardo-Seco, Xabier Bello, et al.
Pediatric Allergy and Immunology : Official Publication of the European Society of Pediatric Allergy and Immunology|April 27, 2023
Cost-effectiveness of omalizumab for the treatment of severe pediatric allergic asthma-Results of a real-life study in SpainMaría Nieto-Cid, Teresa Garriga-Baraut, Ana Mª Plaza-Martín, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|April 27, 2022
Is humoral and cellular response to SARS-CoV-2 vaccine modified by DMT in patients with multiple sclerosis and other autoimmune diseases?Ana Zabalza, Georgina Arrambide, Susana Otero-Romero, et al.
Pageof 139